I-Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3 Argatroban Intermediate High Purity
Umkhiqizi Supply Argatroban Related Intermediate:
I-Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3
N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2
I-3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4
I-Argatroban Monohydrate CAS 141396-28-3
I-Argatroban Anhydrous CAS 74863-84-6
Igama Lekhemikhali | I-Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate |
Omqondofana | I-Ethyl (2R,4R)-4-Methylpipecolate;(2R,4R)-4-Methyl-2-Piperidinecarboxylate;(2R,4R)-Ethyl 4-Methylpiperidine-2-Carboxylate;I-Ethyl-(2R,4R)-4-Methylpiperidine-2-Carboxylate |
Inombolo ye-CAS | 74892-82-3 |
Inombolo yeCAT | I-RF-PI267 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | I-C9H17NO2 |
Isisindo samangqamuzana | 171.24 |
Isimo Sokuthumela | Kuthunyelwe Ngaphansi Kwezinga Lokushisa Le-Ambient |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Icwebezela Uketshezi Oluphuzi Olukhanyayo |
I-Diastereoisomer | ≤1.0% |
Ukuhlanzeka / Indlela Yokuhlaziya | ≥98.0% (GC) |
Izinsimbi Ezisindayo | ≤20ppm |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Argatroban Intermediate (CAS 74863-84-6) |
Iphakheji: Ibhodlela, Umgqomo, 25kg/Umgqomo, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi ohamba phambili kanye nomphakeli we-Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) enekhwalithi ephezulu.I-Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) iphakathi ngokuvamile ekuhlanganiseni kwe-Argatroban Monohydrate (CAS 141396-28-3) noma i-Argatroban (CAS 74863-84-6 ).
I-Argatroban Monohydrate iyi-thrombin inhibitor ethize, eyi-anticoagulant engeyona i-heparin, evimbela ukwakheka kwe-thrombi.I-Argatroban iyi-anticoagulant eyi-molecule encane eqondile ye-thrombin inhibitor.Ngo-2000, i-argatroban yanikezwa ilayisense yi-Food and Drug Administration (FDA) ye-prophylaxis noma ukwelashwa kwe-thrombosis ezigulini ezine-heparin-induced thrombocytopenia (HIT).